Emma Burt

Barts Health NHS Trust

Papers

1

Total Citations

4

H-Index

1

About

Dr. Emma Burt is a translational researcher specializing in prostate cancer tissue biobanking and precision pathology. Her primary contributions lie in developing standardized, clinically-integrated protocols for collecting high-quality prostate tissue specimens for research. In her landmark 2019 paper, "PEOPLE: PatiEnt prOstate samPlEs for rEsearch," Dr. Burt introduced a novel tissue collection pathway that leverages magnetic resonance imaging (MRI) data to precisely target both tumor and benign tissue within fresh radical prostatectomy specimens. This methodological advance ensures that researchers receive anatomically-annotated, high-integrity samples, directly addressing a critical bottleneck in prostate cancer research—the need for representative, well-characterized tissue for biomarker discovery and therapeutic development. While her most-cited work has garnered 4 citations, its impact is foundational, shaping best practices in tissue procurement for multi-institutional studies. Her work is particularly notable for bridging radiology, pathology, and surgical oncology, enabling more reliable translational studies. Dr. Burt’s contributions are essential for researchers seeking to translate imaging findings into molecular insights, making her a key figure in the infrastructure of modern prostate cancer research.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimens
4 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Barts Health NHS Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago